• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Roles of free fatty acid macrophage mediated killing of mycobacteria

Research Project

Project/Area Number 13670272
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Bacteriology (including Mycology)
Research InstitutionShimane medical University

Principal Investigator

TOMIOKA Haruaki  Shimane medical university, medicine, professor, 医学部, 教授 (40034045)

Co-Investigator(Kenkyū-buntansha) SHIMIZU Toshiaki  Shimane medical university, medicine, instructor, 医学部, 助手 (60284030)
AKAKI Tatsuya  Shimane medical university, medicine, instructor, 医学部, 助手 (30252927)
SANO Chiaki  Shimane medical university, medicine, instructor, 医学部, 助手 (70325059)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 2002: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2001: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordsmycobacterium / macrophage / effector molecule / free fatty acid / phospholipase A_2 / phagosome / Mycobacterium tuberculosis / M.avium complex / ホスホリパーゼA_2 / ファゴゾーム
Research Abstract

We previously reported that reactive nitrogen intermediates and free fatty acid (FFA) play important roles in the expression of the activity of mouse peritoneal macrophages (Mφs) against Mycobacterium tuberculosis (MTB) and M. avium complex (MAC). In the present study, we examined the roles of phospholipase A_2 (PLA_2) which specifically releases arachidnic acid (AA) from membrane phospholipid in Mφantimycobacterial activity, and obtained the following results. (1) The intracellular growth of MTB residing in IFN-γ-activated Mφs was accelerated by the quinacrine (PLA_2 inhibitor) and a-TFMK (cPLA_2 inhibitor) (2) The radioactivity of MTB organisms, which were recovered from ^3H-AA loaded Mφs, was progressively increased during Mφ cultivation after MTB infection. Such a phenomenon was blocked when Mφs were treated quinacrine or a-TFMK, indicating that AA translocated to MTB within phagosome in a cPLA_2-dependent fashion. (3) The expression of cPLA_2 and iNO5 mRNAs was increased in IFN-γ- activated Mφ, this is not the case for sPLA_2 mRNA. (4) Fluorescence microscopy on infected Mφs stained with anti cPLA_2 antibody and pyrene labelled cPLA_2 substrates demonstrated that cPLA_2 translocated to mycobacterial organisms within the phagosomes of the Mφs. (5) In the case of mouse peritoneal Mφs, MAP kinase-dependent cPLA_2 phospholylation at the serine residues was observed in the early phase of Mφ cultivation after MTB infection, gradually increased at least for 48 h. On the other hand, constitutive phospholylation of cPLA_2 was observed in RAW Mφs regard less of MTB infection. These findings indicate that cPLA_2 plays important roles in the expression of antimicrobial activity of Mφs against MTB and MAC.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (55 results)

All Other

All Publications (55 results)

  • [Publications] 冨岡 治明: "抗酸菌症とサイトカインネットワーク"臨床免疫. 35・5. 571-579 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 清水 利朗, 佐野 千晶, 佐藤 勝昌, 冨岡 治明 他: "マウス実験的Mycobacterium avium complex感染症に対するKRM-1648のin vivo治療効果ならびにサイトカイン遺伝子発現に及ぼす接種菌量の影響"結核. 76・5. 413-418 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Shimizu T, Sato K, Sano C et al.: "Expression profiles of low molecular mass heat shock proteins by Mycobacterium avium and Mycobacterium intracellulare"FEMS Microbiology Letters. 200. 131-136 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 佐藤 勝昌, 赤木 竜也, 清水 利朗, 冨岡 治明 他: "抗酸菌のマクロファージ(MФ)と肺胞上皮細胞への感染症と細胞内増殖性:MФ内順化菌を用いての検討"結核. 76・2. 54-57 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sano C, Sato K, Shimizu T: "Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex"International Journal of Antimicrobial Agents. 19・2. 139-145 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sato K, Sano C, Sano K, Shimizu T: "Intramacrophage passage of Mycobacterium tuberculosis and Mycobacterium avium complex alters the drug susceptibility testing using macrophage and type II alveolar epithelial cells"Antimicrobial Agents and chemotherapy. 46・2. 519-521 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ohta F, Sano C: "Type II alveolar cells roles in macrophage-mediated host innate resistance to pulumonary Mycobacterial infections by producing proinflammatory cytokines"The Journal of Infectious Diseases. 185. 1139-1147 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sano K, Sato K, Sano C, Shimizu T, Tomioka H: "Comparative profiles of intramacrophage behavior Mycobacterium tuberculosis and Mycobacterium avium complex with different levels of virulence"Microbiology Immunology. 46・7. 483-486 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sato K, Shimizu T, Sano C: "Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other anituberculous drugs"Journal of Infection. 44・3. 160-165 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 佐野 千晶, 佐藤 勝昌, 清水 利朗, 冨岡 治明 他: "Mycobacterium tuberculosisおよびMycobacterium avium complexに対するマクロファージの抗菌活性発現におよぼすATPの作用"日本化学療法学会雑誌. 50・12. 848-853 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 冨岡 治明: "新しい抗結核薬開発の展望"結核. 77・8. 573-584 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ogasawara K, Tomioka H, Shimizu T, Sano C et al.: "Profiles of cell-to-cell interaction of Mycobacterium intracellulare-induced immunosuppressive macrophages with target Tcells in terms of suppressor signal transmission"Clinical and Experimental Immunology. 129・2. 272-280 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 清水 利朗, 佐藤 勝昌, 佐野 千晶, 冨岡 治明 他: "Antisense oligo DNAによる酵素依存性マクロファージ殺菌系および抗菌薬のMycobacterium avium complexに対する活性発現増強の試み"結核. 78・1. 33-35 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 冨岡 治明: "マクロファージの殺菌作用作用における遊離脂肪酸の役割"臨床免疫. 39・1. 85-92 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H: "Type II pneumocytes in the evaluation of drug antimycobacterial activity"Exprt Opinion Pharmacotherapy. 4・2. 127-139 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sano C, Shimizu T, Tomioka H: "Effects of secretory leukocyte protease Inhibitor on the tumor necrosis factor-alpha production and NF-κB activation of lipoplysaccharide-stimulated macrophages"Cytokine. 21・1. 38-42 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 冨岡 治明: "結核 (光山 正雄 編):分担執筆"医薬ジャーナル社. 322-333 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 冨岡 治明: "細菌学 (竹田 美文, 林 秀夫 編):分担執筆"朝倉書店. 563-572 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 冨岡 治明: "病原菌の今日的意味"医薬ジャーナル社. 183-188,694-705 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H: "[review] Profiles of cytokine network in the hosts with mycobacterial infection"Clin Immuno. 35(5). 571-579 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Shimizu T, Ogasawara K, Sato K, Sano C, Tomioka H: "Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at differented challenge doses"Kekkaku. 76(5). 413-418 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Shimizu T, Kajitani H, Sato K, Sano C: "Expression profiles of low molecular mass heat shock proteins by Mycobacterium avium and Mycobacterium intracellulare"FEMS Microbiol Lett.. 200. 131-136 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sato K, Akaki T, Shimizu T, Sano C, Ogasawara K, Tomioka H: "Invasion and intracellular growth of Mycobacterium avium complex adapted to intramacrophage enviroment within macrophages and type II alveolar epitherial cells"Kekkaku. 76(2). 54-57 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sano C, Sato K, Shimizu T: "Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex"Int J Antimicrob Agents. 19(2). 139-145 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sato K, Sano C, Sato K, Shimizu T: "Intramacrophage passage of Mycobacterium tuberculosis and M.avium complex alters the drug susceptibility of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells"Antimicrob Agents Chemother. 46(2). 519-521 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C: "Type II alveolar cells plays roles in macrophage-mediated host innate resistance to pulmonary mycobacteria infections by producing proinflammatory cytokines"J Infect Dis. 185. 1139-1147 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sano K, Sato K, Sano C, Shimizu T, Tomioka H: "Comparative profiles of intramacrophage behavior of Mycobacterium tuberculosis and with different levels of virulence"Microbial Immunol. 46(7). 483-486 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sato K, Shimizu T, Sano C: "Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs"J Infection. 44(3). 160-165 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sano C, Sano K, Sato K, Ogasawara K, Shimizu T, Tomioka H: "Effects of ATP on the in vivo and in vitro Antimicrobial activity of murine macrophages against Mycobacterium avium complex"Japanese J. Chemother. 50(12). 848-853 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H: "[review] Prospects for development of new antituberculous drugs"Kekkaku. 77(8). 573-584 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ogasawara K, Tomioka H, Shimizu T, Sano C, Kawauchi H, Sato K: "Profiles of cell-to-cell interaction of Mycobacterium intracellulare-induced immunosuppressive macrophages with target T cells in terms of suppressor signal transmission"Clin Exp Immunol. 129(2). 272-280 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Shimizu T, Sato K, Sano C, Sano K, Tomioka H: "Effects of antisense oligo DNA on the antimicrobial activity of reactive oxygen intermediates and antimycobacterial agents against Mycobacterium avium complex"Kekkaku. 78(1). 33-35 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H: "[review] Roles of free fatty acids in macrophages-mediated killing and inhibition of microorganisms"Clin Immuno. 39(1). 85-92 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H: "[review] Type II pneumocytes in the evaluation of drug antimycobacterial activity"Expert Opin Pharmacother. 4(2). 127-139 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sano C, Shimizu T, Tomioka H: "Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-κB activation of lipopolysaccharide-stimulated macrophages"Cytokine. 21(1). 38-42 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tomioka H, Sano C, Sato K, Shimizu T: "Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex"International Journal of Antimicrobial Agents. 19・2. 139-145 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tomioka H, Sato K, Sano C, Sano K, Shimizu T: "Intramacrophage passage of Mycobacterium tuberculosis and Mycobacterium avium complex alters the drug susceptibility testing using macrophage and type II alveolar epithelial cells"Antimicrobial Agents and chemotherapy. 46・2. 519-521 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tomioka H, Sato K, Shimizu T, Sano C: "Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs"Journal of Infection. 44・3. 160-165 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ohta F, Sano C: "Type II alveolar cells roles in macrophage-mediated host innate resistance to pulumonary Mycobacterial infections by producing proinflammatory cytokines"The Journal of Infectious Diseases. 185. 1139-1147 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 冨岡 治明: "新しい抗結核薬開発の展望"結核. 77・8. 573-584 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ogasawara K, Tomioka H, Shimizu T, Sano C et al.: "Profiles of cell-to-cell interaction of Mycobacterium intracellulare-induced immunosuppressive macrophages with target Tcells in terms of suppressor signal transmission"Clinical and Experimental Immunology. 129・2. 272-280 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 冨岡 治明: "マクロファージの殺菌作用における遊離脂肪酸の役割"臨床免疫. 39・1. 85-92 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tomioka H: "Type II pneumocytes in the evaluation of drug antimycobacterial activity"Expert Opinion of Pharmacotherapy. 4・2. 127-139 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sano C, Shimizu T, Tomioka H: "Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-α production and NF-κB activation of lipopolysaccharide-stimulated mactophage"Cytokine. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Shimizu T, Tomioka H, Matsuoka M, Sano C: "Profiles of the mRNA expression by macrophage infected with Mycobacterium leprae and Mycobacterium avium complex"International Journal of Leprosy. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 冨岡 治明: "細菌学(竹田 美文,林 秀夫 編):分担執筆"朝倉書店. 563-572 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 冨岡 治朗: "抗酸菌症とサイトカインネットワーク"臨床免疫. 35・5. 571-579 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 清水 利朗, 佐野 千晶, 佐藤 勝昌, 冨岡 治朗 他: "マウス実験的Mycobacterium avium complex感染症に対するKRM-1648のin vivo治療効果ならびにサイトカイン遺伝子発現に及ぼす接種菌量の影響"結核. 76・5. 413-418 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tomioka H, Shimizu T, Sato K, Sano C et al.: "Expression profilesof low molecular mass heat shock proteins by Mycobacterium avium and Mycobacterium intracellulare"FEMS Microbiology Letters. 200. 131-136 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 佐藤 勝昌, 赤木 竜也, 清水 利朗, 冨岡 治朗 他: "抗酸菌のマクロファージ(Mφ)と肺胞上皮細胞への感染性と細胞内増殖性:Mφ内順化菌を用いての検討"結核. 76・2. 54-57 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tomioka H, Sano C, Sato K, Shimizu T: "Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycbacterium avium complex"International Journal of Antimicrobial Agents. 19・2. 139-145 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tomioka H, Sato K, Sano C, Sano K, Shimizu T: "Intramacrophage passage of Mycobacterium tuberculosis and Mycobacterium avium complex alters the drug susceptibility testing using macrophage and type II alveolar epithelial cells"Antimicrobial Agents and chemotherapy. 46・2. 519-521 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tomioka H, sato K, Shimizu T, Sano C: "Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs"Jornal of Infection. (in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ohata F, Sano C: "Type II alveolar cells roles in macrophage-mediated host innate resisitance to pulumonary Mycobacterial infections by producing proinflammatory cytokines"The Jounal of Infectious Diseases. (in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 冨岡 治朗: "結核(光山 正雄 編):分担執筆"医薬ジャーナル社. 414 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi